Last reviewed · How we verify
NCT06086041
Predictive Study on Hearing Rehabilitation After Cochlear Implant
trial testing cochlear implant in Tractography in 50 participants. Status unknown.
1 February 2025
Quick facts
| Lead sponsor | University Hospital, Grenoble |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 17 January 2022 |
| Primary completion | 1 February 2025 |
| Estimated completion | 1 February 2025 |
| Sites | 1 location across France |
Drugs / interventions tested
- cochlear implant
Conditions studied
- Tractography — all drugs for Tractography →
- Cochlear Implant — all drugs for Cochlear Implant →
- Magnetic Resonance Imaging — all drugs for Magnetic Resonance Imaging →
- Hearing Rehabilitation — all drugs for Hearing Rehabilitation →
Sponsor
University Hospital, Grenoble
Who can join
18 and older, any sex, with Tractography or Cochlear Implant. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to display the predictive factors of hearing rehabilitation after cochlear implant surgery in severely to profoundly deaf adults.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06086041
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of cochlear implant
Trials testing the same drug.
- NCT05435612 — Evaluation of Rehabilitation Results in the Single-sided Deafness With Cochlear Implantation · NA · recruiting
- NCT06021132 — Characterisation of Low Frequency Hearing and Vestibular Function in Patients Undergoing Cochlear Implantation · active not recruiting
- NCT03515473 — Subjective and Objective Results With CI Electrode Types · completed
Other University Hospital, Grenoble trials
Trials by the same sponsor.
- NCT07479225 — Circulating Cell-Free DNA for Brain Abscess Diagnosis: A Pilot Study · NA · not yet recruiting
- NCT07477613 — Implantable Brain-Computer Interface for Upper-Limb Recovery After Stroke · NA · not yet recruiting
- NCT07379372 — Bladder Overactivity and Post-Botulinum Toxin Telemonitoring · NA · not yet recruiting
- NCT07166991 — Anesthesia sTrategy foR Organ Procurement In braiN dEath · Phase 3 · recruiting
- NCT07367880 — The Monument Test : A New Tool for Assessing the Ability to Name and Identify Unique Entities. (TeDIMO) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06086041 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Grenoble
- Last refreshed: 17 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06086041.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing